Skip to content

Clinical trials

Kidney Diseases trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Diseases Country / region: Japan Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20131
20141
20153
20161
20181
20192
20202
20212
20224
20232
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting5
Recruiting4
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer3
Novartis Pharmaceuticals3
AstraZeneca2
Kyowa Kirin Co., Ltd.2
Pfizer2
Takeda2
Amicus Therapeutics1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company1
Dimerix Bioscience Pty Ltd1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Diseases24
Renal Insufficiency, Chronic7
Urologic Diseases7
Diabetic Nephropathies5
Glomerulonephritis5
Glomerulonephritis, IGA5
Diabetes Mellitus, Type 24
Diabetes Mellitus3
Carcinoma, Renal Cell2
Genetic Diseases, Inborn2

Trials

Showing 51 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.